Interestingly, heregulin β1 was found to induce GPR30/GPER upregulation in breast cancer cell [20], which can function as a GPCR activating the YAP/TAZ [21], and TAZ can promote ERBB ligands expression including HRG1 [22]. Here, GPER1 is linked to breast carcinoma.